Clinical Trials List
2021-09-01 - 2023-04-30
Phase III
Recruiting6
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 莊涵琄 Division of Infectious Disease
- Mei-Chuan Chen Division of General Internal Medicine
- Shih-Hsin Hsiao Division of Thoracic Medicine
- 黃奕文 Digestive System Department
- Shang-Fu Hsu Division of General Internal Medicine
- Yuam-Jang Lee Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Hung Lee Division of General Internal Medicine
- Tzu-Tao Chen Division of General Internal Medicine
- Yuam-Jang Lee Division of Infectious Disease
- Po-Hao Feng Division of General Internal Medicine
- Kuan-Yuan Chen Division of General Internal Medicine
- kang-Yun LEE Division of Thoracic Medicine
- Ching-Shan Luo Division of General Internal Medicine
- JING-QUAN ZHENG Division of General Internal Medicine
- YUN-KAI YEH Division of General Internal Medicine
- Chien-Hua Tseng Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 歐億聰 Division of Infectious Disease
- Fu-Lun Chen Division of Infectious Disease
- 王婕瑜 Division of General Internal Medicine
- Yu-Tien Tzeng Division of General Internal Medicine
- Ying-Shih Su Division of General Internal Medicine
- Tsong-Yih Ou Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊家瑞 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 曾建豪 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Ho Mao-Wang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
150 participants
-
Global
150 participants
